Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Couchbase (BASE) Financials

Couchbase logo
Annual Income Statements for Couchbase

Annual Income Statements for Couchbase

This table shows Couchbase's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-29 -44 -61 -68 -80 -75
Consolidated Net Income / (Loss)
-29 -40 -58 -68 -80 -75
Net Income / (Loss) Continuing Operations
-29 -40 -58 -68 -80 -75
Total Pre-Tax Income
-28 -39 -57 -67 -79 -73
Total Operating Income
-30 -33 -56 -69 -85 -79
Total Gross Profit
75 92 109 135 158 185
Total Revenue
83 103 124 155 180 209
Operating Revenue
83 103 124 155 180 209
Total Cost of Revenue
7.80 12 15 20 22 25
Operating Cost of Revenue
7.80 12 15 20 22 25
Total Operating Expenses
105 125 165 204 242 263
Selling, General & Admin Expense
16 16 24 33 43 51
Marketing Expense
58 70 89 111 131 142
Research & Development Expense
32 39 52 58 64 71
Impairment Charge
- - 0.00 0.00 5.16 0.00
Restructuring Charge
- 0.00 0.00 1.66 0.05 0.00
Total Other Income / (Expense), net
1.85 -5.86 -0.96 1.86 5.71 5.80
Interest Expense
4.66 6.97 0.66 0.10 0.04 0.06
Other Income / (Expense), net
6.51 1.11 -0.30 1.96 5.75 5.86
Income Tax Expense
0.77 1.04 1.02 1.04 1.36 1.80
Basic Earnings per Share
($5.33) ($7.71) ($2.37) ($1.53) ($1.70) ($1.45)
Weighted Average Basic Shares Outstanding
5.49M 5.72M 25.78M 44.79M 47.18M 51.31M
Diluted Earnings per Share
($5.33) ($7.71) ($2.37) ($1.53) ($1.70) ($1.45)
Weighted Average Diluted Shares Outstanding
5.49M 5.72M 25.78M 44.79M 47.18M 51.31M
Weighted Average Basic & Diluted Shares Outstanding
- - 44.17M 45.61M 49.26M 53.10M
Cash Dividends to Common per Share
- $0.00 $0.00 $0.00 $0.00 $0.00

Quarterly Income Statements for Couchbase

This table shows Couchbase's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025
Net Income / (Loss) Attributable to Common Shareholders
-17 -17 -22 -21 -16 -21 -21 -20 -18 -16 -18
Consolidated Net Income / (Loss)
-17 -17 -22 -21 -16 -21 -21 -20 -18 -16 -18
Net Income / (Loss) Continuing Operations
-17 -17 -22 -21 -16 -21 -21 -20 -18 -16 -18
Total Pre-Tax Income
-16 -17 -21 -21 -16 -21 -21 -19 -17 -15 -17
Total Operating Income
-17 -19 -23 -22 -18 -23 -23 -21 -19 -16 -19
Total Gross Profit
34 36 35 37 41 45 46 45 45 49 50
Total Revenue
39 42 41 43 46 50 51 52 52 55 57
Operating Revenue
39 42 41 43 46 50 51 52 52 55 57
Total Cost of Revenue
4.88 5.95 5.92 5.91 5.11 5.14 5.68 6.46 6.56 6.26 6.86
Operating Cost of Revenue
4.88 5.95 5.92 5.91 5.11 5.14 5.68 6.46 6.56 6.26 6.86
Total Operating Expenses
50 54 58 59 58 68 68 66 64 64 69
Selling, General & Admin Expense
8.83 8.21 9.63 10 11 12 13 13 13 13 11
Marketing Expense
27 29 33 32 32 34 38 36 34 34 38
Research & Development Expense
14 15 15 16 16 16 18 17 17 18 19
Total Other Income / (Expense), net
0.29 1.91 1.41 1.24 1.30 1.77 1.53 1.71 1.77 0.79 2.04
Interest Expense
0.03 0.03 0.03 0.02 0.00 - 0.00 0.03 0.02 0.01 0.02
Other Income / (Expense), net
0.32 1.94 1.43 1.26 1.30 1.77 1.53 1.74 1.79 0.80 2.05
Income Tax Expense
0.38 0.03 0.75 0.00 0.00 0.61 0.00 0.56 0.69 0.55 0.87
Basic Earnings per Share
($0.37) ($0.37) ($0.48) ($0.44) ($0.34) ($0.44) ($0.42) ($0.39) ($0.35) ($0.29) ($0.33)
Weighted Average Basic Shares Outstanding
44.93M 44.79M 45.84M 46.71M 47.59M 47.18M 49.79M 50.82M 51.83M 51.31M 53.65M
Diluted Earnings per Share
($0.37) ($0.37) ($0.48) ($0.44) ($0.34) ($0.44) ($0.42) ($0.39) ($0.35) ($0.29) ($0.33)
Weighted Average Diluted Shares Outstanding
44.93M 44.79M 45.84M 46.71M 47.59M 47.18M 49.79M 50.82M 51.83M 51.31M 53.65M
Weighted Average Basic & Diluted Shares Outstanding
45.17M 45.61M 46.41M 47.07M 48.07M 49.26M 50.31M 51.32M 52.35M 53.10M 54.08M
Cash Dividends to Common per Share
- - $0.00 - - - $0.00 - - - $0.00

Annual Cash Flow Statements for Couchbase

This table details how cash moves in and out of Couchbase's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Net Change in Cash & Equivalents
9.18 19 58 -55 0.91 -11
Net Cash From Operating Activities
-22 -39 -42 -41 -27 -16
Net Cash From Continuing Operating Activities
-22 -39 -42 -41 -27 -16
Net Income / (Loss) Continuing Operations
-29 -40 -58 -68 -80 -75
Consolidated Net Income / (Loss)
-29 -40 -58 -68 -80 -75
Depreciation Expense
0.71 2.01 2.82 3.17 2.42 2.28
Amortization Expense
7.99 11 14 17 15 15
Non-Cash Adjustments To Reconcile Net Income
3.73 4.87 11 29 55 66
Changes in Operating Assets and Liabilities, net
-4.93 -17 -11 -22 -19 -24
Net Cash From Investing Activities
-4.71 -22 -92 -23 15 -4.85
Net Cash From Continuing Investing Activities
-4.71 -22 -92 -23 15 -4.85
Purchase of Property, Plant & Equipment
-4.71 -2.82 -0.82 -5.65 -4.71 -3.02
Purchase of Investments
0.00 -20 -112 -145 -131 -101
Sale and/or Maturity of Investments
0.00 0.90 21 127 151 99
Net Cash From Financing Activities
36 81 192 9.71 13 9.94
Net Cash From Continuing Financing Activities
36 81 192 9.71 13 9.94
Issuance of Common Equity
0.00 0.00 215 4.48 2.00 3.52
Other Financing Activities, net
0.98 2.19 7.49 5.22 11 6.42
Effect of Exchange Rate Changes
-0.14 0.16 -0.42 -0.40 -0.56 -0.62
Cash Interest Paid
3.85 5.95 0.62 0.10 0.04 0.05
Cash Income Taxes Paid
0.51 0.87 0.80 0.78 2.47 1.77

Quarterly Cash Flow Statements for Couchbase

This table details how cash moves in and out of Couchbase's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025
Net Change in Cash & Equivalents
-7.56 1.67 5.79 -4.80 5.47 -5.56 10 11 -30 -2.50 -2.49
Net Cash From Operating Activities
-15 -10 -7.18 -0.52 -13 -6.45 1.56 -4.85 -17 4.36 -6.78
Net Cash From Continuing Operating Activities
-15 -10 -7.18 -0.52 -13 -6.45 1.56 -4.85 -17 4.36 -6.78
Net Income / (Loss) Continuing Operations
-17 -17 -22 -21 -16 -21 -21 -20 -18 -16 -18
Consolidated Net Income / (Loss)
-17 -17 -22 -21 -16 -21 -21 -20 -18 -16 -18
Depreciation Expense
0.84 0.87 0.89 0.75 0.40 0.39 0.40 0.36 0.76 0.76 0.85
Amortization Expense
4.14 3.97 4.54 4.70 4.50 1.19 3.20 4.18 4.38 2.33 4.79
Non-Cash Adjustments To Reconcile Net Income
7.64 6.73 9.22 12 12 21 16 16 16 19 14
Changes in Operating Assets and Liabilities, net
-11 -5.15 0.05 2.57 -14 -8.01 3.21 -5.84 -20 -1.96 -8.25
Net Cash From Investing Activities
5.56 10 10 -6.87 15 -2.67 3.70 15 -15 -7.74 1.38
Net Cash From Continuing Investing Activities
5.56 10 10 -6.87 15 -2.67 3.70 15 -15 -7.74 1.38
Purchase of Property, Plant & Equipment
-1.62 -1.55 -1.29 -1.07 -1.07 -1.29 -1.00 -1.07 -0.58 -0.38 -1.86
Purchase of Investments
-41 -34 -7.82 -56 -26 -41 -19 -18 -38 -25 -13
Sale and/or Maturity of Investments
48 46 19 51 42 39 24 34 23 18 16
Net Cash From Financing Activities
1.63 1.19 2.76 2.73 3.86 3.58 5.09 0.84 2.84 1.17 2.64
Net Cash From Continuing Financing Activities
1.63 1.19 2.76 2.73 3.86 3.58 5.09 0.84 2.84 1.17 2.64
Issuance of Common Equity
0.96 - 0.85 - 1.15 - 1.80 - 1.72 - 1.42
Other Financing Activities, net
0.67 1.19 1.92 2.73 2.70 3.58 3.29 0.84 1.12 1.17 1.22
Effect of Exchange Rate Changes
-0.02 0.46 -0.10 -0.15 -0.29 -0.02 -0.26 0.06 -0.12 -0.29 0.27
Cash Interest Paid
0.03 0.03 0.03 0.02 - - 0.00 0.01 0.02 0.02 0.02
Cash Income Taxes Paid
0.26 0.16 0.29 0.12 0.84 1.22 0.59 0.55 0.29 0.34 -0.43

Annual Balance Sheets for Couchbase

This table presents Couchbase's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Total Assets
117 277 253 248 261
Total Current Assets
104 263 229 224 228
Cash & Equivalents
37 96 40 41 31
Short-Term Investments
20 110 128 112 117
Accounts Receivable
36 37 40 45 49
Prepaid Expenses
2.45 8.56 8.23 10 15
Other Current Assets
8.35 12 13 15 17
Plant, Property, & Equipment, net
6.51 4.29 7.43 5.33 7.21
Total Noncurrent Assets
7.14 9.46 16 18 25
Other Noncurrent Operating Assets
7.14 9.46 16 18 25
Total Liabilities & Shareholders' Equity
117 277 253 248 261
Total Liabilities
104 94 103 117 133
Total Current Liabilities
73 90 95 113 127
Accounts Payable
2.43 1.92 1.41 4.87 2.19
Accrued Expenses
4.15 3.23 6.08 4.58 8.44
Current Deferred Revenue
57 69 72 82 94
Current Employee Benefit Liabilities
9.11 16 13 18 21
Other Current Liabilities
- 0.00 3.12 3.21 1.36
Total Noncurrent Liabilities
31 3.22 7.82 4.83 5.65
Noncurrent Deferred Revenue
4.54 2.71 3.28 2.75 2.69
Other Noncurrent Operating Liabilities
1.36 0.51 4.54 2.08 2.96
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-246 183 150 130 128
Total Preferred & Common Equity
-246 183 150 130 128
Preferred Stock
0.00 0.00 0.00 0.00 0.00
Total Common Equity
-246 183 150 130 128
Common Stock
37 525 562 621 693
Retained Earnings
-284 -342 -410 -491 -565
Accumulated Other Comprehensive Income / (Loss)
0.00 -0.20 -0.81 0.06 0.12

Quarterly Balance Sheets for Couchbase

This table presents Couchbase's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 10/31/2021 4/30/2022 7/31/2022 10/31/2022 4/30/2023 7/31/2023 10/31/2023 4/30/2024 7/31/2024 10/31/2024 4/30/2025
Total Assets
260 267 265 242 249 244 232 243 236 222 247
Total Current Assets
248 245 242 220 226 219 207 218 211 194 214
Cash & Equivalents
141 48 46 39 46 41 47 52 63 33 28
Short-Term Investments
66 153 146 138 117 124 110 108 94 109 114
Accounts Receivable
23 25 29 23 42 32 30 35 31 29 44
Prepaid Expenses
8.19 8.01 9.66 7.77 6.84 8.03 7.45 10 10 11 12
Other Current Assets
9.22 12 12 12 13 13 13 13 13 13 17
Plant, Property, & Equipment, net
4.98 4.34 5.64 6.73 8.03 8.58 9.63 6.11 7.05 7.00 10
Total Noncurrent Assets
7.14 17 17 16 16 16 15 18 18 21 22
Other Noncurrent Operating Assets
7.14 17 17 16 16 16 15 18 18 21 22
Total Liabilities & Shareholders' Equity
260 267 265 242 249 244 232 243 236 222 247
Total Liabilities
68 93 98 84 109 108 97 114 109 96 121
Total Current Liabilities
64 85 90 77 102 102 90 110 107 91 115
Accounts Payable
3.52 2.64 5.58 3.52 6.87 3.16 3.17 4.07 5.03 4.72 4.57
Accrued Expenses
2.53 2.95 4.10 3.31 4.81 4.87 3.40 3.81 3.37 3.98 7.31
Current Deferred Revenue
48 68 67 58 79 80 72 90 82 68 92
Current Employee Benefit Liabilities
- 8.03 11 9.05 8.50 11 9.12 8.94 14 12 9.76
Other Current Liabilities
- 2.72 3.08 3.04 3.06 2.98 2.98 3.11 2.67 2.15 0.80
Total Noncurrent Liabilities
4.02 7.92 7.96 7.24 6.75 6.49 6.52 3.96 2.20 4.51 6.19
Noncurrent Deferred Revenue
2.73 2.29 2.47 2.58 2.87 3.22 3.78 2.57 1.03 0.83 3.25
Other Noncurrent Operating Liabilities
1.30 5.63 5.49 4.66 3.87 3.27 2.74 1.39 1.17 3.68 2.94
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
191 174 166 158 141 136 135 129 127 127 126
Total Preferred & Common Equity
191 174 166 158 141 136 135 129 127 127 126
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
191 174 166 158 141 136 135 129 127 127 126
Common Stock
520 537 545 553 574 589 605 641 658 676 709
Retained Earnings
-329 -362 -377 -394 -432 -453 -469 -512 -532 -550 -583
Accumulated Other Comprehensive Income / (Loss)
-0.03 -0.88 -1.04 -1.38 -0.49 -0.30 -0.11 -0.22 0.03 0.12 0.20

Annual Metrics And Ratios for Couchbase

This table displays calculated financial ratios and metrics derived from Couchbase's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Growth Metrics
- - - - - -
Revenue Growth
0.00% 25.16% 19.61% 25.32% 16.28% 16.35%
EBITDA Growth
0.00% -24.55% -111.84% -19.42% -28.87% 9.61%
EBIT Growth
0.00% -34.13% -76.92% -19.09% -16.97% 7.61%
NOPAT Growth
0.00% -9.02% -70.07% -23.21% -21.96% 6.96%
Net Income Growth
0.00% -36.66% -45.63% -17.63% -17.07% 6.90%
EPS Growth
0.00% -44.65% 69.26% 35.44% -11.11% 14.71%
Operating Cash Flow Growth
0.00% -80.07% -6.12% 0.94% 34.70% 41.14%
Free Cash Flow Firm Growth
0.00% 0.00% -639.43% -51.82% -1.47% -8.72%
Invested Capital Growth
0.00% 0.00% -23.48% 20.67% -28.68% 15.75%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 4.42% 4.93% 2.36%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -7.82% -14.97% 6.10%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -5.71% -5.72% 7.38%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -9.19% -5.09% 7.91%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -5.19% -6.35% 7.20%
EPS Q/Q Growth
0.00% 0.00% 0.00% -233.04% -4.29% 9.38%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 8.61% -22.45% 12.25% 40.58%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.19% 11.02%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 5.81% -8.68% -28.98%
Profitability Metrics
- - - - - -
Gross Margin
90.55% 88.75% 88.04% 86.91% 87.73% 88.08%
EBITDA Margin
-18.33% -18.24% -32.31% -30.79% -34.12% -26.51%
Operating Margin
-36.77% -32.03% -45.54% -44.77% -46.96% -37.55%
EBIT Margin
-28.88% -30.95% -45.78% -43.50% -43.76% -34.75%
Profit (Net Income) Margin
-35.45% -38.71% -47.13% -44.24% -44.54% -35.64%
Tax Burden Percent
102.69% 102.68% 101.77% 101.54% 101.72% 102.47%
Interest Burden Percent
119.54% 121.80% 101.16% 100.15% 100.05% 100.08%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -296.61% -59.21% -41.08% -57.13% -57.86%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -27.28% -28.71% -25.43% -31.46% -28.64%
Return on Assets (ROA)
0.00% -34.12% -29.56% -25.86% -32.02% -29.37%
Return on Common Equity (ROCE)
0.00% 5,420.43% 19.00% -41.08% -57.13% -57.86%
Return on Equity Simple (ROE_SIMPLE)
0.00% 16.23% -31.78% -45.58% -61.48% -58.50%
Net Operating Profit after Tax (NOPAT)
-21 -23 -39 -49 -59 -55
NOPAT Margin
-25.74% -22.42% -31.88% -31.34% -32.87% -26.29%
Net Nonoperating Expense Percent (NNEP)
0.00% -105.52% -15.85% -10.67% -13.05% -13.03%
Return On Investment Capital (ROIC_SIMPLE)
- - - -32.29% -45.37% -43.14%
Cost of Revenue to Revenue
9.45% 11.25% 11.96% 13.09% 12.27% 11.92%
SG&A Expenses to Revenue
18.86% 15.01% 19.43% 21.57% 23.70% 24.18%
R&D to Revenue
38.38% 37.76% 41.80% 37.31% 35.59% 33.69%
Operating Expenses to Revenue
127.32% 120.78% 133.57% 131.69% 134.69% 125.63%
Earnings before Interest and Taxes (EBIT)
-24 -32 -57 -67 -79 -73
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-15 -19 -40 -48 -61 -56
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 5.58 4.45 9.21 7.28
Price to Tangible Book Value (P/TBV)
0.00 0.00 5.58 4.45 9.21 7.28
Price to Revenue (P/Rev)
2.04 1.63 8.27 4.32 6.68 4.43
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 3.83 6.60 3.23 5.82 3.73
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 1.85 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 1.85 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -2.37 -1.21 -1.12 -1.15 -1.17
Leverage Ratio
0.00 8.69 2.00 1.59 1.78 1.97
Compound Leverage Factor
0.00 10.59 2.03 1.59 1.79 1.97
Debt to Total Capital
0.00% 64.92% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 64.92% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 676.13% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -641.05% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 -1.32 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 1.69 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 -1.32 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 -1.08 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 1.38 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 -1.08 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 -2.12 5.34 2.00 3.59 1.50
Noncontrolling Interest Sharing Ratio
0.00% 1,927.46% 132.09% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
0.00 1.42 2.91 2.42 1.99 1.79
Quick Ratio
0.00 1.27 2.69 2.19 1.76 1.54
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -4.74 -35 -53 -54 -59
Operating Cash Flow to CapEx
-461.93% -1,389.78% -5,076.19% -729.45% -570.98% -524.11%
Free Cash Flow to Firm to Interest Expense
0.00 -0.68 -53.44 -526.95 -1,255.88 -978.58
Operating Cash Flow to Interest Expense
-4.67 -5.62 -63.38 -407.77 -625.42 -263.80
Operating Cash Flow Less CapEx to Interest Expense
-5.68 -6.03 -64.62 -463.67 -734.95 -314.13
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.88 0.63 0.58 0.72 0.82
Accounts Receivable Turnover
0.00 2.88 3.40 4.05 4.25 4.45
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 15.88 22.89 26.43 28.23 33.41
Accounts Payable Turnover
0.00 4.78 6.79 12.17 7.04 7.08
Days Sales Outstanding (DSO)
0.00 126.86 107.24 90.23 85.85 81.98
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 76.29 53.72 30.00 51.84 51.56
Cash Conversion Cycle (CCC)
0.00 50.57 53.52 60.23 34.02 30.42
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 -18 -23 -18 -23 -20
Invested Capital Turnover
0.00 -11.22 -6.00 -7.59 -8.73 -9.80
Increase / (Decrease) in Invested Capital
0.00 -18 -4.32 4.70 -5.17 3.66
Enterprise Value (EV)
0.00 396 815 500 1,048 781
Market Capitalization
168 168 1,021 668 1,202 929
Book Value per Share
$0.00 ($43.09) $4.20 $3.33 $2.71 $2.44
Tangible Book Value per Share
$0.00 ($43.09) $4.20 $3.33 $2.71 $2.44
Total Capital
0.00 38 183 150 130 128
Total Debt
0.00 25 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 25 0.00 0.00 0.00 0.00
Net Debt
0.00 -32 -206 -168 -154 -147
Capital Expenditures (CapEx)
4.71 2.82 0.82 5.65 4.71 3.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -26 -33 -34 -42 -46
Debt-free Net Working Capital (DFNWC)
0.00 31 173 135 112 101
Net Working Capital (NWC)
0.00 31 173 135 112 101
Net Nonoperating Expense (NNE)
8.02 17 19 20 21 20
Net Nonoperating Obligations (NNO)
0.00 -32 -206 -168 -154 -147
Total Depreciation and Amortization (D&A)
8.70 13 17 20 17 17
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -25.33% -26.93% -21.82% -23.25% -22.01%
Debt-free Net Working Capital to Revenue
0.00% 29.71% 139.78% 86.89% 62.09% 48.25%
Net Working Capital to Revenue
0.00% 29.71% 139.78% 86.89% 62.09% 48.25%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($2.37) ($1.53) ($1.70) ($1.45)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 25.78M 44.79M 47.18M 51.31M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($2.37) ($1.53) ($1.70) ($1.45)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 25.78M 44.79M 47.18M 51.31M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 44.17M 45.61M 49.26M 53.10M
Normalized Net Operating Profit after Tax (NOPAT)
-21 -23 -39 -47 -56 -55
Normalized NOPAT Margin
-25.74% -22.42% -31.88% -30.59% -30.85% -26.29%
Pre Tax Income Margin
-34.53% -37.70% -46.31% -43.57% -43.78% -34.78%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-5.12 -4.59 -86.22 -666.88 -1,832.21 -1,213.18
NOPAT to Interest Expense
-4.56 -3.32 -60.03 -480.40 -1,376.18 -917.64
EBIT Less CapEx to Interest Expense
-6.13 -4.99 -87.46 -722.78 -1,941.74 -1,263.52
NOPAT Less CapEx to Interest Expense
-5.57 -3.73 -61.28 -536.30 -1,485.72 -967.98
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% -8.47% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Couchbase

This table displays calculated financial ratios and metrics derived from Couchbase's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
25.09% 18.71% 17.63% 8.41% 18.82% 20.34% 25.20% 19.59% 12.69% 9.65% 10.12%
EBITDA Growth
0.02% -41.79% -5.91% -54.07% -0.42% -64.07% -5.38% 2.68% -8.52% 37.94% 35.98%
EBIT Growth
-4.72% -28.16% -7.96% -37.68% 0.19% -25.74% 0.43% 6.34% -7.39% 27.83% 20.07%
NOPAT Growth
-7.11% -46.05% -18.67% -43.56% -5.73% -22.11% -0.03% 3.75% -9.65% 29.92% 16.40%
Net Income Growth
-4.73% -25.52% -10.29% -34.37% 2.53% -28.82% 4.02% 3.66% -11.67% 27.06% 15.79%
EPS Growth
0.00% -116.02% -6.67% -29.41% 8.11% -18.92% 12.50% 11.36% -2.94% 34.09% 21.43%
Operating Cash Flow Growth
25.46% -284.73% 16.57% 93.22% 13.43% 36.78% 121.71% -834.49% -32.58% 167.57% -535.09%
Free Cash Flow Firm Growth
128.15% 0.00% -247.18% 3.18% -877.43% 39.71% 63.08% -43.90% -95.19% -38.50% -290.41%
Invested Capital Growth
-206.86% 20.67% 15.32% -17.64% -11.52% -28.68% -37.19% 2.53% 29.01% 15.75% 49.65%
Revenue Q/Q Growth
-3.10% 7.95% -1.51% 5.23% 6.20% 9.33% 2.47% 0.51% 0.08% 6.38% 2.92%
EBITDA Q/Q Growth
-14.77% -3.84% -39.29% 3.21% 25.20% -69.67% -6.19% 10.62% 16.59% 2.98% 6.67%
EBIT Q/Q Growth
-8.70% -1.78% -27.38% 2.30% 21.20% -28.21% -0.87% 8.10% 9.65% 13.83% -11.72%
NOPAT Q/Q Growth
-8.92% -11.51% -21.79% 2.95% 19.79% -28.79% 0.23% 6.62% 8.62% 17.68% -19.01%
Net Income Q/Q Growth
-8.51% 0.38% -31.67% 5.60% 21.29% -31.66% 1.90% 5.24% 8.76% 14.00% -13.25%
EPS Q/Q Growth
-8.82% 0.00% -29.73% 8.33% 22.73% -29.41% 4.55% 7.14% 10.26% 17.14% -13.79%
Operating Cash Flow Q/Q Growth
-92.29% 30.69% 29.62% 92.77% -2,355.30% 49.38% 124.17% -411.10% -248.35% 125.79% -255.64%
Free Cash Flow Firm Q/Q Growth
111.65% -1,462.49% -12.60% 45.81% 6.49% -5.66% 31.05% -111.22% -26.85% 25.03% -94.37%
Invested Capital Q/Q Growth
25.54% 5.81% -25.81% -33.33% 29.41% -8.68% -34.13% 5.28% 48.59% -28.98% 19.84%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
87.36% 85.70% 85.55% 86.30% 88.84% 89.74% 88.93% 87.47% 87.30% 88.61% 87.87%
EBITDA Margin
-29.30% -28.19% -38.22% -35.16% -24.76% -38.43% -32.17% -28.61% -23.85% -21.75% -19.72%
Operating Margin
-43.03% -44.45% -54.96% -50.69% -38.29% -45.11% -43.91% -40.80% -37.26% -28.83% -33.34%
EBIT Margin
-42.21% -39.80% -51.47% -47.79% -35.46% -41.58% -40.93% -37.42% -33.79% -27.37% -29.71%
Profit (Net Income) Margin
-43.25% -39.92% -53.36% -47.87% -35.48% -42.73% -40.90% -38.56% -35.16% -28.42% -31.28%
Tax Burden Percent
102.31% 100.15% 103.55% 100.09% 100.07% 102.76% 99.93% 102.89% 103.96% 103.76% 105.18%
Interest Burden Percent
100.16% 100.15% 100.12% 100.09% 100.00% 100.00% 100.00% 100.15% 100.10% 100.09% 100.09%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-37.26% -41.08% -44.75% -50.22% -51.40% -57.13% -58.74% -59.92% -61.40% -57.86% -55.90%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-24.93% -23.26% -32.08% -30.89% -25.65% -29.90% -31.67% -31.03% -30.43% -22.55% -26.06%
Return on Assets (ROA)
-25.55% -23.33% -33.26% -30.94% -25.67% -30.72% -31.65% -31.97% -31.66% -23.42% -27.43%
Return on Common Equity (ROCE)
-37.26% -41.08% -44.75% -50.22% -51.40% -57.13% -58.74% -59.92% -61.40% -57.86% -55.90%
Return on Equity Simple (ROE_SIMPLE)
-41.19% 0.00% -50.04% -55.94% -55.74% 0.00% -61.45% -62.02% -63.45% 0.00% -56.55%
Net Operating Profit after Tax (NOPAT)
-12 -13 -16 -15 -12 -16 -16 -15 -13 -11 -13
NOPAT Margin
-30.12% -31.12% -38.47% -35.49% -26.80% -31.57% -30.74% -28.56% -26.08% -20.18% -23.34%
Net Nonoperating Expense Percent (NNEP)
-2.70% -1.96% -3.35% -2.99% -2.38% -3.47% -3.22% -3.21% -3.14% -3.01% -2.97%
Return On Investment Capital (ROIC_SIMPLE)
- -8.62% - - - -12.13% - - - -8.68% -10.46%
Cost of Revenue to Revenue
12.64% 14.30% 14.45% 13.70% 11.16% 10.26% 11.07% 12.53% 12.70% 11.39% 12.13%
SG&A Expenses to Revenue
22.90% 19.72% 23.48% 24.24% 23.44% 23.64% 24.52% 24.49% 24.45% 23.32% 19.75%
R&D to Revenue
36.30% 36.04% 37.52% 37.77% 34.71% 32.92% 34.77% 33.67% 33.87% 32.54% 33.95%
Operating Expenses to Revenue
130.39% 130.15% 140.52% 137.00% 127.13% 134.84% 132.84% 128.27% 124.56% 117.43% 121.21%
Earnings before Interest and Taxes (EBIT)
-16 -17 -21 -21 -16 -21 -21 -19 -17 -15 -17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-11 -12 -16 -15 -11 -19 -17 -15 -12 -12 -11
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.63 4.45 4.97 5.71 5.42 9.21 9.21 7.62 6.51 7.28 7.43
Price to Tangible Book Value (P/TBV)
3.63 4.45 4.97 5.71 5.42 9.21 9.21 7.62 6.51 7.28 7.43
Price to Revenue (P/Rev)
3.87 4.32 4.35 4.71 4.27 6.68 6.25 4.86 4.03 4.43 4.36
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
2.67 3.23 3.34 3.70 3.36 5.82 5.41 4.07 3.34 3.73 3.70
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.07 -1.12 -1.16 -1.19 -1.14 -1.15 -1.20 -1.23 -1.14 -1.17 -1.18
Leverage Ratio
1.44 1.59 1.64 1.68 1.62 1.78 1.82 1.83 1.73 1.97 1.92
Compound Leverage Factor
1.44 1.59 1.64 1.69 1.62 1.78 1.82 1.83 1.74 1.97 1.92
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
2.91 2.66 2.41 2.67 2.83 4.36 4.37 3.25 2.93 2.23 2.48
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.85 2.42 2.22 2.16 2.30 1.99 1.99 1.97 2.13 1.79 1.87
Quick Ratio
2.60 2.19 2.02 1.95 2.07 1.76 1.78 1.75 1.87 1.54 1.62
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1.30 -18 -20 -11 -10 -11 -7.34 -15 -20 -15 -29
Operating Cash Flow to CapEx
-910.33% -656.99% -557.53% -48.46% -1,195.40% -501.95% 156.68% -454.55% -2,897.94% 1,162.13% -364.68%
Free Cash Flow to Firm to Interest Expense
49.83 -706.10 -795.08 -598.41 0.00 0.00 0.00 -534.47 -1,156.52 -1,052.79 -1,909.87
Operating Cash Flow to Interest Expense
-566.15 -408.12 -287.24 -28.83 0.00 0.00 0.00 -167.24 -993.82 311.29 -452.20
Operating Cash Flow Less CapEx to Interest Expense
-628.35 -470.24 -338.76 -88.33 0.00 0.00 0.00 -204.03 -1,028.12 284.50 -576.20
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.59 0.58 0.62 0.65 0.72 0.72 0.77 0.83 0.90 0.82 0.88
Accounts Receivable Turnover
6.58 4.05 4.82 5.35 6.47 4.25 4.96 6.24 6.94 4.45 5.48
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
25.31 26.43 26.02 23.11 20.97 28.23 26.92 25.43 24.61 33.41 26.37
Accounts Payable Turnover
5.24 12.17 4.53 5.19 6.84 7.04 3.99 5.47 6.04 7.08 6.05
Days Sales Outstanding (DSO)
55.46 90.23 75.77 68.27 56.40 85.85 73.62 58.49 52.63 81.98 66.62
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
69.70 30.00 80.57 70.36 53.37 51.84 91.38 66.71 60.44 51.56 60.31
Cash Conversion Cycle (CCC)
-14.25 60.23 -4.80 -2.08 3.03 34.02 -17.76 -8.23 -7.82 30.42 6.31
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-19 -18 -23 -30 -21 -23 -31 -29 -15 -20 -16
Invested Capital Turnover
-11.68 -7.59 -6.51 -5.87 -8.47 -8.73 -7.07 -6.66 -11.21 -9.80 -9.17
Increase / (Decrease) in Invested Capital
-13 4.70 4.10 -4.54 -2.21 -5.17 -8.44 0.77 6.20 3.66 15
Enterprise Value (EV)
396 500 537 609 576 1,048 1,029 809 683 781 795
Market Capitalization
573 668 701 775 732 1,202 1,189 965 825 929 937
Book Value per Share
$3.53 $3.33 $3.09 $2.92 $2.87 $2.71 $2.62 $2.52 $2.47 $2.44 $2.38
Tangible Book Value per Share
$3.53 $3.33 $3.09 $2.92 $2.87 $2.71 $2.62 $2.52 $2.47 $2.44 $2.38
Total Capital
158 150 141 136 135 130 129 127 127 128 126
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-177 -168 -164 -166 -157 -154 -160 -156 -142 -147 -142
Capital Expenditures (CapEx)
1.62 1.55 1.29 1.07 1.07 1.29 1.00 1.07 0.58 0.38 1.86
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-35 -34 -40 -48 -39 -42 -51 -53 -39 -46 -42
Debt-free Net Working Capital (DFNWC)
143 135 124 117 117 112 109 104 103 101 100
Net Working Capital (NWC)
143 135 124 117 117 112 109 104 103 101 100
Net Nonoperating Expense (NNE)
5.06 3.66 6.10 5.34 3.98 5.59 5.22 5.16 4.69 4.53 4.49
Net Nonoperating Obligations (NNO)
-177 -168 -164 -166 -157 -154 -160 -156 -142 -147 -142
Total Depreciation and Amortization (D&A)
4.98 4.83 5.43 5.45 4.90 1.58 4.50 4.55 5.13 3.09 5.65
Debt-free, Cash-free Net Working Capital to Revenue
-23.27% -21.82% -24.79% -29.42% -22.96% -23.25% -27.02% -26.44% -18.97% -22.01% -19.63%
Debt-free Net Working Capital to Revenue
96.28% 86.89% 76.87% 71.48% 68.33% 62.09% 57.13% 52.09% 50.40% 48.25% 46.44%
Net Working Capital to Revenue
96.28% 86.89% 76.87% 71.48% 68.33% 62.09% 57.13% 52.09% 50.40% 48.25% 46.44%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.37) ($0.37) ($0.48) ($0.44) ($0.34) ($0.44) ($0.42) ($0.39) ($0.35) ($0.29) ($0.33)
Adjusted Weighted Average Basic Shares Outstanding
44.93M 44.79M 45.84M 46.71M 47.59M 47.18M 49.79M 50.82M 51.83M 51.31M 53.65M
Adjusted Diluted Earnings per Share
($0.37) ($0.37) ($0.48) ($0.44) ($0.34) ($0.44) ($0.42) ($0.39) ($0.35) ($0.29) ($0.33)
Adjusted Weighted Average Diluted Shares Outstanding
44.93M 44.79M 45.84M 46.71M 47.59M 47.18M 49.79M 50.82M 51.83M 51.31M 53.65M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
45.17M 45.61M 46.41M 47.07M 48.07M 49.26M 50.31M 51.32M 52.35M 53.10M 54.08M
Normalized Net Operating Profit after Tax (NOPAT)
-12 -12 -16 -15 -12 -16 -16 -15 -13 -11 -13
Normalized NOPAT Margin
-30.12% -28.32% -38.40% -35.49% -26.80% -31.57% -30.74% -28.56% -26.08% -20.18% -23.34%
Pre Tax Income Margin
-42.28% -39.86% -51.53% -47.83% -35.46% -41.58% -40.93% -37.48% -33.82% -27.39% -29.74%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-625.96 -662.56 -844.00 -1,145.22 0.00 0.00 0.00 -665.76 -1,026.12 -1,073.64 -1,119.53
NOPAT to Interest Expense
-446.71 -518.06 -630.92 -850.46 0.00 0.00 0.00 -508.06 -791.99 -791.65 -879.34
EBIT Less CapEx to Interest Expense
-688.15 -724.68 -895.52 -1,204.72 0.00 0.00 0.00 -702.55 -1,060.41 -1,100.43 -1,243.53
NOPAT Less CapEx to Interest Expense
-508.90 -580.18 -682.44 -909.96 0.00 0.00 0.00 -544.85 -826.28 -818.44 -1,003.34
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Couchbase, Inc. (BASE) has reported quarterly results across the last four years. Below is a concise, investor-focused view of trends in revenue, profitability, cash flow, and liquidity, highlighting notable positives, neutral factors, and potential negatives for retail investors.

  • Revenue trend improving over time: quarterly operating revenue has risen from the mid-$40s million range in 2023–2024 to about $56.5 million in Q1 2026, signaling top-line growth.
  • High gross margins consistently observed: total gross profit has been roughly 85–90% of revenue across recent quarters (e.g., Q1 2026 gross profit around $49.7M on $56.5M revenue), indicating strong product margins.
  • Solid liquidity with strong short-term assets: as of Q1 2026, cash & equivalents plus short-term investments total about $141.8M, while total current liabilities are around $114.6M, implying a healthy current ratio (~1.86) and quick liquidity above 1.0.
  • Financing activity provides occasional liquidity: quarterly financing activity has included equity issuance and other financing inflows, contributing to liquidity in certain periods (e.g., net cash from continuing financing activities showing positive inflows in some quarters).
  • Operating cash flow is mixed but often negative: net cash from operating activities is negative in most quarters, with occasional small positives (e.g., Q1 2025 showed a modest positive, but several later quarters were negative), indicating ongoing cash burn from core operations.
  • High operating expenses relative to revenue: total operating expenses run high (SG&A, marketing, and R&D typically 60–70%+ of revenue in many quarters), which pressures operating margins despite solid gross margins.
  • Periodic restatements and data revisions noted: several quarters show restated results or calculated/adjusted figures, which can complicate year-over-year comparisons.
  • Persistent quarterly net losses: net income (and earnings per share) remain negative across the observed periods, with continuing losses in the mid-to-high teens or low twenties millions per quarter, signaling ongoing profitability challenges.
  • Negative free cash flow pressures from investing activities: investing outflows (e.g., acquisitions of investments and capital expenditures) and negative operating cash flow combine to negative free cash flow in many periods, reducing retained cash.
  • Expense growth versus top-line growth could limit margins: while revenue has improved, substantial marketing/R&D and other operating costs continue to outpace gross profit growth, contributing to margin compression over time.
05/08/26 07:02 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Couchbase's Financials

When does Couchbase's fiscal year end?

According to the most recent income statement we have on file, Couchbase's financial year ends in January. Their financial year 2025 ended on January 31, 2025.

How has Couchbase's net income changed over the last 5 years?

Couchbase's net income appears to be on an upward trend, with a most recent value of -$74.65 million in 2025, rising from -$29.26 million in 2020. The previous period was -$80.18 million in 2024.

What is Couchbase's operating income?
Couchbase's total operating income in 2025 was -$78.66 million, based on the following breakdown:
  • Total Gross Profit: $184.51 million
  • Total Operating Expenses: $263.16 million
How has Couchbase's revenue changed over the last 5 years?

Over the last 5 years, Couchbase's total revenue changed from $82.52 million in 2020 to $209.47 million in 2025, a change of 153.8%.

How much debt does Couchbase have?

Couchbase's total liabilities were at $132.98 million at the end of 2025, a 13.3% increase from 2024, and a 28.2% increase since 2021.

How much cash does Couchbase have?

In the past 4 years, Couchbase's cash and equivalents has ranged from $30.54 million in 2025 to $95.69 million in 2022, and is currently $30.54 million as of their latest financial filing in 2025.

How has Couchbase's book value per share changed over the last 5 years?

Over the last 5 years, Couchbase's book value per share changed from 0.00 in 2020 to 2.44 in 2025, a change of 243.8%.



Financial statements for NASDAQ:BASE last updated on 6/17/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners